Novo Nordisk: Don't Miss Buying This Dip

Ozempic maker Novo Nordisk A/S ( NVO ), was down by no less than 22% in yesterday's trading session. A series of key developments occurred recently, including the E.U.-U.S. trade deal, the appointment of a new CEO, and a brief financial update for Q2 2025. But the key Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflec ...